The Human Pluripotent Stem Cell Registry (hPSCreg) is a public registry and data
portal dedicated to human pluripotent stem cell (hPSC) lines, including both human
embryonic stem cells (hESC) and human induced pluripotent stem cells (hiPSC). It is
hosted and operated by Charité – Universitätsmedizin Berlin (University Medicine
Berlin), one of the largest university hospitals in Europe, in Germany. hPSCreg was
established to serve the international stem cell research community by providing a
centralized, standardized, and freely accessible database of characterized human
pluripotent stem cell lines.
The registry addresses a fundamental challenge in the field of stem cell research:
the lack of harmonized, transparent, and verifiable information about the thousands
of pluripotent stem cell lines generated by laboratories, biobanks, and companies
around the world. By collecting, validating, and publishing detailed information on
each cell line, hPSCreg supports reproducibility, ethical compliance, and
responsible sharing of biological resources across the global research landscape.
Background and Mission
hPSCreg originated from projects funded by the European Commission and has grown into
a globally recognized resource. Its core mission is to promote responsible research
with human pluripotent stem cells by making reliable and standardized information
about these cells openly available. The registry underpins transparency in the
provenance, ethical sourcing, and scientific characterization of stem cell lines,
thereby helping researchers select appropriate, well-documented cell lines for their
experiments.
A key part of the registry's mission is to encourage compliance with ethical and
legal standards governing the derivation and use of human pluripotent stem cells. By
requiring documentation of donor consent, ethical approvals, and provenance
information, hPSCreg helps ensure that cell lines listed in its database have been
generated in accordance with recognized ethical frameworks.
What hPSCreg Does
hPSCreg functions as both a data repository and a service provider that supports the
identification, registration, characterization, and dissemination of human
pluripotent stem cell lines. Its activities cover several interconnected areas:
- Collecting and curating detailed information about individual hESC and hiPSC lines
from providers worldwide.
- Assigning standardized, unique, and machine-readable names to each registered cell
line to eliminate confusion caused by inconsistent naming conventions.
- Reviewing and validating ethical and provenance documentation associated with each
cell line.
- Publishing verified data through an openly accessible web-based portal.
- Supporting the international harmonization of stem cell nomenclature and data
standards.
Products and Services
Cell Line Registration and Unique Naming
One of hPSCreg's central services is the registration of human pluripotent stem cell
lines and the assignment of a standardized unique name to each line. The registry
uses an internationally agreed-upon naming standard that encodes information such as
the depositor, the type of cell line, and other identifying attributes into a
consistent, human- and machine-readable format. This standardized naming service is
widely used by researchers, journals, and funding bodies to unambiguously identify
cell lines in publications and datasets. Researchers can request a name for a new
cell line directly through the registry.
Searchable Cell Line Database
hPSCreg provides a comprehensive, freely accessible, and searchable online database
of registered pluripotent stem cell lines. Users can browse and query the database
using a wide range of criteria, including cell line name, cell type (hESC or hiPSC),
donor characteristics, disease association, genetic modifications, reprogramming
methods, and the depositor or provider. Each cell line entry aggregates detailed
information, allowing researchers to compare lines and select those most suitable for
their scientific needs.
Detailed Cell Line Data Sheets
For each registered cell line, hPSCreg compiles structured data sheets that present
information across multiple domains, including:
- Origin and derivation details, such as the source tissue and reprogramming or
derivation methods.
- Donor information, including relevant clinical and phenotypic data where available.
- Genotype and genetic modification data, including disease-associated mutations and
engineered alterations.
- Characterization data documenting pluripotency, differentiation potential, and
quality control assessments.
- Ethical and legal information, including consent and ethics approval status.
- Availability and provider contact details.
Ethical and Provenance Evaluation
hPSCreg offers a service in which submitted cell lines undergo review of their
ethical and provenance documentation. This includes assessment of donor informed
consent, ethical committee approvals, and the legal basis for derivation and use.
Cell lines that meet documented ethical standards are flagged accordingly, giving
researchers confidence that the resources they use are ethically sourced. This
service is particularly valuable for meeting the requirements of funding agencies,
regulatory authorities, and scientific journals.
Support for Clinical-Grade and Research Cell Lines
The registry accommodates both research-grade and clinical-grade pluripotent stem
cell lines. For lines intended for clinical or therapeutic applications, hPSCreg
captures additional relevant documentation, supporting the growing field of
regenerative medicine and cell therapy where traceability and quality assurance are
critical.
Data Standards and Interoperability
hPSCreg contributes to the development and adoption of standardized data formats and
ontologies for describing pluripotent stem cell lines. The registry supports
interoperability with other biomedical databases and resources, enabling integration
of cell line information into broader research infrastructures. This standardization
work helps ensure that data remains consistent, comparable, and reusable across
different platforms and institutions.
Integration with the Research Community
The registry serves as a bridge between cell line depositors, biobanks, and end
users. It links registered cell lines to their originating publications and, where
applicable, to biobanks and repositories from which the lines can be obtained. This
connectivity streamlines the process of locating and acquiring specific stem cell
lines for research purposes.
Who Uses hPSCreg
hPSCreg serves a broad international audience, including:
- Academic and clinical researchers seeking well-characterized stem cell lines.
- Biobanks and cell repositories depositing and sharing their collections.
- Scientific journals requiring standardized cell line identification in
publications.
- Funding agencies and regulatory bodies requiring documentation of ethical
compliance.
- Companies and institutions developing stem cell–based therapies and research tools.
Significance in the Field
By centralizing verified information about human pluripotent stem cell lines,
hPSCreg plays an important role in advancing rigor, reproducibility, and ethical
integrity in stem cell science. The registry reduces duplication of effort, helps
prevent the use of misidentified or poorly documented cell lines, and promotes
transparency in a rapidly expanding and scientifically significant research field.
As a resource maintained by Charité – Universitätsmedizin Berlin, hPSCreg combines
institutional credibility with a commitment to open access, making it a trusted and
widely referenced tool for the global stem cell research community.
Summary
The Human Pluripotent Stem Cell Registry (hPSCreg), operated by Charité –
Universitätsmedizin Berlin in Germany, is a public and freely accessible registry
that collects, validates, and disseminates standardized information about human
embryonic and induced pluripotent stem cell lines. Through its cell line
registration and unique naming service, searchable database, detailed data sheets,
ethical and provenance evaluation, and support for data standardization, hPSCreg
provides essential infrastructure for transparent, ethical, and reproducible stem
cell research worldwide.